Publikationen, an denen er mitarbeitet Manuel Muro Amador (21)

2012

  1. Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients

    Transplant Immunology, Vol. 26, Núm. 2-3, pp. 94-100

2007

  1. Impact of Recipient HLA-C in Liver Transplant: A Protective Effect of HLA-Cw*07 on Acute Rejection

    Human Immunology, Vol. 68, Núm. 1, pp. 51-58

2006

  1. HBV and HCV Infections and Acute Rejection Differentially Modulate CD95 and CD28 Expression on Peripheral Blood Lymphocytes After Liver Transplantation

    Human Immunology, Vol. 67, Núm. 11, pp. 884-893

  2. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome

    Transplant International, Vol. 19, Núm. 2, pp. 98-104

  3. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients

    Tissue Antigens, Vol. 67, Núm. 2, pp. 117-126

  4. TGF-β1 gene polymorphism in liver graft recipients

    Transplant Immunology, Vol. 17, Núm. 1, pp. 55-57

2005

  1. Evaluation of CD86 gene polymorphism at + 1057 position in liver transplant recipients

    Transplant Immunology, Vol. 15, Núm. 1, pp. 69-74

  2. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: Experience of one centre

    Transplant Immunology, Vol. 14, Núm. 2, pp. 91-97

2003

  1. Human leukocyte antigen-C in short- and long- term liver graft acceptance

    Liver Transplantation, Vol. 9, Núm. 3, pp. 218-227

  2. Impact of HLA-C on acute rejection in liver transplantation

    Transplantation Proceedings

  3. Relationship between CDC cross-match in liver recipients and antibody screening by flow cytometry

    Transplantation Proceedings

2002

  1. DQA1 and DPB1 genes polymorphism on acute rejection development in liver transplantation

    Transplantation Proceedings, Vol. 34, Núm. 8, pp. 3302-3303

  2. Expression of CD95 and apoptosis induction in peripheral blood cells from liver graft recipients

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 280-282

  3. Recipient factors analysis in long-term allograft survival of liver transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 290-291

2001

  1. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?

    Transplantation Proceedings, Vol. 33, Núm. 1-2, pp. 1384-1385

  2. DQA1 and DPB1 loci polymorphism on acute rejection development in liver transplant

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 248

  3. Liver allograft survival in specifically presensitizied recipients with a positive T-lymphocytotoxic crossmatch

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 265

2000

  1. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant

    Human Immunology, Vol. 61, Núm. 7, pp. 658-669

1999

  1. CD30+ and CD27- lymphocytes in liver transplant: Th2 cytokine secretion

    Transplantation Proceedings

  2. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance

    Human Immunology, Vol. 60, Núm. 6, pp. 500-509